Ewelina Szczepanek-Parulska
Overview
Explore the profile of Ewelina Szczepanek-Parulska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milewska-Kobos E, Szczepanek-Parulska E, Marciniak M, Wrotkowska E, Cieslewicz M, Dobrowolska A, et al.
Peptides
. 2025 Feb;
185:171355.
PMID: 39921103
Since its discovery, nesfatin-1 (N1) has been recognised as an anorexigenic agent potentially related to obesity pathogenesis and development, including its modulatory effect on the brain's reward system and eating...
2.
Kaluzna M, Szczepanek-Parulska E, Moczko J, Czlapka-Matyasik M, Katulska K, Ziemnicka K, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769400
Gaucher disease (GD), the most common ultra-rare metabolic disorder, results from lipid accumulation. Systemic inflammation, cellular stress, and metabolic dysfunction may influence endocrine function, including the thyroid. This study evaluated...
3.
Borowczyk M, Jodlowska-Siewert E, Filipowicz D, Komarnicki P, Verburg F, Ziemnicka K, et al.
Pol Arch Intern Med
. 2025 Jan;
135(2).
PMID: 39764798
Introduction: Differentiated thyroid cancer (DTC) is the most common endocrine malignancy, with incidence rising in recent decades. Despite a favorable prognosis, management remains complex, often involving thyroidectomy followed by radioactive...
4.
Asaad S, Chillon T, Filipowicz D, Wilms B, Strenge F, Szczepanek-Parulska E, et al.
Biofactors
. 2024 Sep;
51(1):e2123.
PMID: 39345206
The thyroid hormone (TH) status is routinely assessed by thyrotropin (TSH) and thyroxine (T4). Both biomarkers are mainly regulated by TH receptor beta, whereas many peripheral organs employ the alpha...
5.
Cieslewicz M, Andryszak N, Pelka K, Szczepanek-Parulska E, Ruchala M, Kunikowska J, et al.
Diagnostics (Basel)
. 2024 Aug;
14(15).
PMID: 39125566
Background: Primary hyperparathyroidism is a common endocrine disorder characterised by excessive parathormone secretion that results in hypercalcemia, primarily caused by parathyroid adenoma. Accurate localisation of hyperfunctioning tissue is essential for...
6.
Olejarz M, Szczepanek-Parulska E, Krygier A, Wrotkowska E, Sawicka-Gutaj N, Ruchala M
Arch Immunol Ther Exp (Warsz)
. 2024 Jul;
72(1).
PMID: 39032009
Elevated immunoglobulin G4 (IgG4) serum antibodies are an important feature of IgG4-related disease. However, IgG4 antibodies can play a role in autoimmune thyroid disorders. In this study, we aimed to...
7.
Szczepanek-Parulska E, Placzkiewicz-Jankowska E
Pol Arch Intern Med
. 2024 May;
134(5).
PMID: 38804240
No abstract available.
8.
Czarnywojtek A, Gut P, Dyrka K, Sowinski J, Sawicka-Gutaj N, Katulska K, et al.
Endokrynol Pol
. 2024 Apr;
75(2):130-139.
PMID: 38646982
Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumour. The average survival time for a patient diagnosed with GBM, using standard treatment methods, is several months. Authors of the...
9.
Olejarz M, Szczepanek-Parulska E, Ruchala M
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1354098.
PMID: 38628593
Dyslipidemia is one of the most common disorders worldwide, which, if left untreated, results in a multitude of complications. Thus proper diagnostics, which includes identifying of secondary causes of dyslipidemia...
10.
Dera-Szymanowska A, Filipowicz D, Misan N, Szymanowski K, Chillon T, Asaad S, et al.
Nutrients
. 2023 Sep;
15(18).
PMID: 37764830
The aim of this study was to compare the iron and calcium status in singleton and twin pregnancies and to assess whether there is an increased risk for iron and...